| Literature DB >> 27117741 |
Karol Jelonek, Piotr Widlak, Monika Pietrowska1.
Abstract
A large variety of vesicles is actively secreted into the extracellular space by most type of cells. The smallest nanoparticles (30-120 nm), called exosomes, are known to transport their cargo (nucleic acids, proteins and lipids) between diverse locations in the body. Specific content of exosomes and their influence on recipient cells depends primarily on the type of the secretory (donor) cell, yet several studies highlight the importance of environmental stress on which the donor cells are exposed. Ionizing radiation, which induces damage to DNA and other structures of a target cell, is one of well-recognized stress conditions influencing behavior of affected cells. A few recent studies have evidenced radiationinduced changes in composition of exosomes released from irradiated cells and their involvement in radiation-related communication between cells. Inducible pathways of exosome secretion activated in irradiated cells are regulated by TSAP6 protein (the transmembrane protein tumor suppressor-activated pathway 6), which is transcriptionally regulated by p53, hence cellular status of this major DNA damage response factor affects composition and secretion rate of exosomes released from target cells. Moreover, exosomes released from irradiated cells have been shown to mediate the radiation-induced bystander effect. Understanding radiation-related mechanisms involved in exosome formation and "makeup" of their cargo would shed light on the role of exosomes in systemic response of cells, tissues and organisms to ionizing radiation which may open new perspectives in translational medicine and anticancer-treatment.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27117741 PMCID: PMC5029112 DOI: 10.2174/0929866523666160427105138
Source DB: PubMed Journal: Protein Pept Lett ISSN: 0929-8665 Impact factor: 1.890
Exosomal components significantly changed after donor cell exposure to ionizing radiation.
|
|
|
|
|
|
|---|---|---|---|---|
| Human epithelial prostate cell carcinoma (22Rv1) | 4 Gy | 96 h | Increased level of B7-H3 (CD276) | [ |
| Human serum | Radiotherapy treatment | No information | Increased level of HSP72 protein | [ |
| Human glioblastoma multiforme (U87MG) | 4 Gy | 24-48 h | Abnormally increased levels of CTGF mRNA and IGFBP2 protein | [ |
| Human head and neck squamous cell carcinoma (FaDu) | 2 Gy | 18 h | Increased levels of proteins involved in transcription/translation (EIFs, PSMs, RPLs and RPSs), cell cycle/division (chaperones, ubiquitination-related factors and proteasome components) and cell signaling (ARFs, RABs and RASs proteins); | [ |
Examples of RIBEs perpetuated by exosomes in recipient cells.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Human breast cancer cell line (MCF-7) | MCF-7 | 2 Gy | 4 h | DNA (comet assay) and chromosomal (metaphases analysis) damage after 24 h of incubation | [ |
| Human keratinocyte cells (HaCaT) | HaCaT | 0.005 Gy; 0.05 Gy ; 0.5 Gy | 1 h | Cell death (the alamarBlue® assay) after 72 h of incubation | [ |
| Human breast cancer cell line (MCF-7) | MCF-7 | 2 Gy | 4 h | DNA (comet assay) and chromosomal (metaphases analysis damage) after 24 h of incubation up to 20 cell-doublings | [ |